C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports

François Parquin, Elise Cuquemelle, Eve Camps, Jérôme Devaquet, Mathilde Phillips Houllbracq, Edouard Sage, Olivier Brugière, Morgan Le Guen, Elisabeth Longchampt, Stéphanie Malard, Clément Picard, Jean Luc Taupin, Antoine Roux

Source: Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019
Journal Issue: April
Disease area: -

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
François Parquin, Elise Cuquemelle, Eve Camps, Jérôme Devaquet, Mathilde Phillips Houllbracq, Edouard Sage, Olivier Brugière, Morgan Le Guen, Elisabeth Longchampt, Stéphanie Malard, Clément Picard, Jean Luc Taupin, Antoine Roux. C1-esterase inhibitor treatment for antibody-mediated rejection after lung transplantation: two case reports. Eur Respir J, 55 (4) 1902027; 10.1183/13993003.02027-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004



A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010



Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003

Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001

Rapamycin in patients with chronic lung rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

Lymphoma's and rejection after lung transplantation: balancing the immunosuppression
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005

Respiratory and renal functional evolutionary profiles after introduction of everolimus and minimizing doses of calcineurin inhibitors in lung transplant recipients, a descriptive observational study
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008


Dose-dependent pro- or anti-proliferative effects of calcineurin inhibitors in bronchiolitis obliterans following allogeneic stem cell transplantation
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011

The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients
Source: Eur Respir J, 53 (5) 1900055; 10.1183/13993003.00055-2019
Year: 2019



II-17 upregulation in BAL-fluid during acute rejection after lung transplantation: a 3 months follow-up
Source: Eur Respir J 2004; 24: Suppl. 48, 180s
Year: 2004

Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016

The murine orthotopic single lung transplantation model for chronic rejection: work in progress?
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018



Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004



Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016